These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28383438)

  • 1. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
    Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
    Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison on the efficacy and safety of different occlusion devices for the treatment of patients with patent foramen ovale].
    Liu WJ; Zhang YS; Cheng GS; Du YJ; He L; Wang XY; He XM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):485-490. PubMed ID: 28648024
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.
    Toggweiler S; Moccetti F; Conrad N; Loretz L; Madanchi M; Bossard M; Attiger-Toller A; Cuculi F; Wolfrum M
    J Invasive Cardiol; 2024 Apr; 36(4):. PubMed ID: 38412438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
    Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
    Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
    J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
    Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
    Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
    Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure.
    Ateş AH; Yorgun H; Canpolat U; Şener YZ; Okşul M; Kaya EB; Şahiner ML; Topcuoğlu MA; Arsava EM; Aytemir K
    Turk Kardiyol Dern Ars; 2021 Jan; 49(1):29-39. PubMed ID: 33390571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
    Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
    Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
    J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and efficacy of left atrial appendage closure combined with patent foramen ovale closure for atrial fibrillation patients with patent foramen ovale].
    Zhao ZH; Song X; Wang SH; Luo J; Wu YB; Zhu Q; Fang M; Huan Q; Zhang XG; Tian B; Gu W; Zhu LN; Hao SW; Ning ZP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):257-262. PubMed ID: 35340144
    [No Abstract]   [Full Text] [Related]  

  • 15. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
    Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
    Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.
    Kasner SE; Sondergaard L; Nakum M; Gomez Montero M; Hashim M; Landaas EJ
    J Med Econ; 2024; 27(1):337-343. PubMed ID: 38373018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
    Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F
    EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.